Eribulin mesylate drug may help extend lives of women with advanced breast cancer

[News]

A new drug, based on a natural extract from sea sponge, may help to extend the lives of women with advanced breast cancer, UK scientists have found. A research team at the University of Leeds and St James's Institute of Oncology led an international trial of the new chemotherapy drug, eribulin mesylate.

More... (http://www.news-medical.net/news/20100611/Eribulin-mesylate-drug-may-help-extend-lives-of-women-with-advanced-breast-cancer.aspx)